Ann Dermatol.  2018 Dec;30(6):725-727. 10.5021/ad.2018.30.6.725.

Cutaneous Pseudolymphoma Derived from Ruptured Milia

• Lee M
• Kim J
• Kim DY

• KMID: 2428932
• DOI: http://doi.org/10.5021/ad.2018.30.6.725

Abstract

No abstract available.

MeSH Terms

Pseudolymphoma*

Figure

• 

  Fig. 1 Clinical characteristics. (A) Initial clinical presentation of patient. Multiple confluent erythematous plaques on the forehead and left side of her face; (B) Recurrence of erythematous plaques with multiple milia found within the lesions; (C) Significant improvement of the lesions after the extraction of milia. We received the patient's consent form about publishing all photographic materials.

• 

  Fig. 2 Histological findings. (A) Histological examination shows lymphoid nodules consisting of dense mixed lymphocytic infiltrates (H&E; left, ×40 and right, ×200 magnification). (B) Histologic examination showing dense lymphocytic infiltration visibly derived from rupture of milia (H&E, ×40 magnification).

Reference

1. Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin Dermatol. 2010; 28:568–574.

2. Cristaudo A, Forte G, Bocca B, Petrucci F, Muscardin L, Trento E, et al. Permanent tattoos: evidence of pseudolymphoma in three patients and metal composition of the dyes. Eur J Dermatol. 2012; 22:776–780.

3. Imafuku S, Ito K, Nakayama J. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis. Br J Dermatol. 2012; 166:675–678.

4. Nihal M, Mikkola D, Horvath N, Gilliam AC, Stevens SR, Spiro TP, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003; 34:617–622.

5. Burg G, Dummer R, Haeffner A, Kempf W, Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol. 2001; 137:949–952.